SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-19-000814
Filing Date
2019-03-18
Accepted
2019-03-18 21:06:29
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form411577del_03182019.html 4  
1 OWNERSHIP DOCUMENT form411577del_03182019.xml 4 4130
  Complete submission text file 0000921895-19-000814.txt   5744
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Issuer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PLX PHARMA,INC.8285 EL RIO STREET SUITE 210 HOUSTON TX 77054
Business Address
Deliargyris Efthymios (Reporting) CIK: 0001751617 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36351 | Film No.: 19690014